SCHEMBL6939841

SCHEMBL6939841

CCC(O)C(O)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.60
AOC3 Q16853 5/20 0.55
ADRA2C P18825 2/20 0.52
KDM4E B2RXH2 2/20 0.52
ADRA2A P08913 1/20 0.52
HIF1A Q16665 1/20 0.52
SLC6A2 P23975 3/20 0.52
SLC6A4 P31645 3/20 0.52
SLC6A3 Q01959 3/20 0.52
ALDH1A1 P00352 2/20 0.50
TRPA1 O75762 1/20 0.50
CYP3A4 P08684 2/20 0.48
CYP2D6 P10635 2/20 0.48
CHRM2 P08172 1/20 0.48
ADRA1A P35348 1/20 0.48
RGS12 O14924 1/20 0.48
GLA P06280 1/20 0.48
CYP2C9 P11712 1/20 0.48
PKM P14618 1/20 0.48
ALOX15 P16050 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18087746 1.00 LMNA (0.60) LMNAAOC3ADRA2CKDM4EADRA2A
SCHEMBL9480262 0.84 SLC6A2 (0.61) LMNAAOC3ADRA2CKDM4EADRA2A
SCHEMBL12512912 0.84 SLC6A2 (0.61) LMNAAOC3ADRA2CKDM4EADRA2A
SCHEMBL24990899 0.82 AOC3 (0.61) LMNAAOC3ADRA2CKDM4EADRA2A
SCHEMBL7913345 0.81 LMNA (0.60) LMNAAOC3ADRA2CKDM4EADRA2A
SCHEMBL13567490 0.81 LMNA (0.60) LMNAAOC3ADRA2CKDM4EADRA2A
SCHEMBL14388207 0.79 AOC3 (0.58) LMNAAOC3ADRA2CKDM4EADRA2A
SCHEMBL21524526 0.79 LMNA (0.58) LMNAAOC3ADRA2CKDM4EADRA2A
SCHEMBL10255083 0.79 AOC3 (0.58) LMNAAOC3ADRA2CKDM4EADRA2A
SCHEMBL14387920 0.79 AOC3 (0.58) LMNAAOC3ADRA2CKDM4EADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115847939-A High-strength composite board for building and preparation method thereof 连云港万泰装饰新材料有限公司 2023-03-28 CN claimed
EP-0317998-A2 Manufacturing method of optically-active 1,2-diols KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1989-05-31 EP claimed
CN-115847939-A High-strength composite board for building and preparation method thereof 连云港万泰装饰新材料有限公司 2023-03-28 CN disclosed
EP-2883899-A1 METHOD FOR PRODUCING BRANCHED AROMATIC POLYCARBONATE RESIN Mitsubishi Gas Chemical Company, Inc. (JP) 2015-06-17 EP disclosed
CN-101909592-B External preparation for skin KAO CORP 2013-01-30 CN disclosed
CN-101909586-B Skin external preparation for acne skin KAO CORP 2013-01-02 CN disclosed
CN-101909592-A External preparation for skin KAO CORP 2010-12-08 CN disclosed
CN-101909586-A Skin external preparation for acne skin KAO CORP 2010-12-08 CN disclosed
US-20040076690-A1 Compositions for weight loss with improved taste KANEBO, LTD. (JP) 2004-04-22 US disclosed
JP-2003342223-A CLATHRATE COMPOUND AND COMPOSITION CONTAINING THE SAME KANEBO LTD 2003-12-03 JP disclosed
US-4276223-A DECARBOXYLATION OF CYCLIC CARBONATE, MANGANESE SALT CATALYST PHILLIPS PETROLEUM COMPANY (US) 1981-06-30 US disclosed
US-4266046-A CYCLIC CARBONATE ESTERS REACTED WITH AROMATIC POLYCARBOXYLIC ACIDS TO PRODUCE BIS(HYDROXYALKYL) ESTERS OR POLYESTERS IN THE PRESENCE OF CATALYSTS PHILLIPS PETROLEUM COMPANY (US) 1981-05-05 US disclosed
US-4257966-A FROM THE CORRESPONDING CYCLIC CARBAMATE PHILLIPS PETROLEUM COMPANY (US) 1981-03-24 US disclosed
EP-0011417-A1 Optically active or racemic aminal derivatives, process for preparing same and for converting same to alpha-hydroxyaldehydes SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1980-05-28 EP disclosed
US-4192810-A Preparation of vicinal epoxides PHILLIPS PETROLEUM COMPANY (US) 1980-03-11 US disclosed
US-4111965-A FROM A CYCLIC CARBONATE SULFONIUM HALIDE CATALYST PHILLIPS PETROLEUM COMPANY (US) 1978-09-05 US disclosed
US-4069234-A FROM CARBONATE ESTERS, PHOSPHONIUM, SULFONIUM, AND SULFOXONIUM HALIDES AND METAL SALT CATALYSTS PHILLIPS PETROLEUM COMPANY (US) 1978-01-17 US disclosed
US-3954440-A Substituted 2-hydroxy-2-phenylbutylsulfonate compounds THE DOW CHEMICAL COMPANY (US) 1976-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040076690-A1 Compositions for weight loss with improved taste FABP4, FABP6, TAS2R60 LMNA 3320/4885AOC3 3938/4885ADRA2C 1403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.